Risk of Immunologic Reactions During Monthly Therapy for Hansen Disease

This cohort study examines the type 1 and type 2 reactions associated with the monthly regimen of rifampin, moxifloxacin, and minocycline among patients with leprosy.

Corresponding Author: Andrea D. Maderal, MD, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, 1600 NW 10th Ave, RMSB Building, Miami, FL 33136 (amaderal@med.miami.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.